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Introduction
Approximately 35 years ago our laboratory suggested that a progressive, 
dietary deficiency and/or a metabolic-induced loss of magnesium (Mg) 
from the body beginning early in life, particularly during development of 
the coronary arteries, could lead to coronary arterial vasospasm, ischemic 
heart disease, and sudden cardiac death (SCD) [1,2]. Ever since this work 
was published, a number of clinical studies have been done and published 
which support this hypothesis, at least in adults [3-10]. However, little or 
no studies have been published to either confirm or deny this hypothesis 
in either infants or young children.
Autopsies of children, who have died as a consequence of accidents, 
have often demonstrated early signs of atherogenesis (e.g., fatty streaks 
on the walls of the aorta and carotid arteries in young children as early 
as six years of age) [11]. It should be noted that atherosclerosis is the 
number-one cause of premature death in developing countries, including 
the United States and plays a major role in etiology of hypertension and 
strokes.
 Disturbances in diet are known to produce inflammatory lesions, 
promote lipid deposition and accelerated growth, and transformation 
of the smooth muscle cells in the vascular walls [11-16]. Reduction in 
dietary Mg intake has been demonstrated, experimentally, to result in 
hypertension [17-20], atherogenesis [15,21-27], and stroke [15,27-34]. 
Hypermagnesemic diets have been shown to ameliorate hypertension, 
atherogenesis, stroke and certain inflammatory responses [34-41]. In 
the Western World, dietary intake of Mg is subnormal, with shortfalls of 
between 65 and 225 mg of Mg/day, depending upon geographic region 
[42,43]. Newly compiled USA NHANES data indicate that approximately 
65% of the American population is Mg deficient [44]. Several epidemiologic 
studies in North America and Europe have shown that children and adults 
consuming Western-type diets are low in Mg content as are pregnant 
women (i.e., 30-50% of the RDA for these populations) [42-44].
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Abstract
Magnesium (Mg) is a co-factor for more than 500 enzymes, and is the second most abundant intracellular cation after potassium. It is vital in 
numerous physiological, cellular and biochemical functions and systems necessary for life. Approximately 35 years ago, our laboratory suggested 
that a progressive, dietary deficiency and/or metabolic induced loss of Mg from the body, beginning early in life, particularly during development 
of the coronary arteries, could lead to coronary arterial vasospasm, ischemic heart disease, and sudden-cardiac death (SCD). Herein, we review 
evidence for a brand-new, novel hypothesis which combines knowledge suggesting a combined role for hypomagnesemia and platelet-activating 
factor (PAF) which may provide insights into unexplained SCD in infants, children, and young adults. This review documents what takes place in 
the cardiovascular system when the body and its tissues are subjected to lower than normal dietary Mg intake, and also provides new evidence 
for a series of heretofore unknown actions of PAF that are most likely involved and/or trigger coronary arterial vasospasm in the presence of low 
concentrations of ionized Mg levels. The roles of vascular remodeling, NF-κB and proto-oncogenes are considered to play major roles in this 
hypothesis.
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Low Ionized Mg measurements in Serum: Relationship to 
Ischemic Heart Disease and Vascular Remodeling
Using sensitive, specific Mg2+ - ion selective electrodes, it has been 
shown that patients with ischemic heart disease, essential hypertension, 
renal-diseased induced hypertension, and strokes exhibit significant 
depletion of serum and cellular ionized Mg2+, the physiologically-active 
Mg [14,25,29-32,45-54]. In addition, we have shown that pregnant 
women with gestational diabetes, preeclampsia, and difficult labors 
also demonstrate depletion of serum as well as cellular levels of ionized 
Mg2+ [48,49,52-54]. Such low levels of ionized Mg, when mimicked in 
vitro, result in spasms of peripheral, coronary, placental, neonatal, and 
cerebral vascular smooth muscle (VSM) cells, rapid cellular influx and 
intracellular release of free Ca2+, well as increasing vascular reactivity 
to numerous neurogenic and humoral molecules [2-4,14,19,25-31,55-
62]. Dietary deficiency of Mg in rats has been shown to not only cause 
hypertension [17,20], but to also cause vascular remodeling (i.e., arteriolar 
wall hypertrophy of unknown origin), rarefaction of capillaries (known 
itself to result in hypertension) [18], stiffening of arterial walls [20], as well 
as release of cytokines and chemokines (involved in inflammatory and 
atherogenic responses) [63-65].
Magnesium Deficiency Results in Activation of NF-κB and 
Proto-Oncogenes
The nuclear factor-kappa B (NF-κB) and proto-oncogenes (e.g., c-fos, 
c-jun) are two major regulators of growth, differentiation, cell migration, 
and cell death (e.g., apoptosis) [66-69]. NF-κB is a transcription factor 
and a pleiotropic regulator of numerous genes involved in inflammatory 
responses, hypertension, and atherogenesis [12,66,67,69]. Both NF-κB 
and the proto-oncogenes are thought to be pivotal in numerous vascular 
disease processes such as inflammation, atherogenesis, hypertension, and 
ischemic heart disease [12,66,67,69]. It is, however, not clear as to what 
initiates expression of these molecular and cellular events, particularly 
with respect to how Mg deficiency impacts on these vascular events and 
how low Mg causes (or predisposes to) hypertension, intense vasospasm, 
inflammation, stroke-like events, cardiac failure , and SCD. Experiments 
performed in-vitro and in-vivo on cells and living animals have 
demonstrated that short-term magnesium deficiency (MgD) results in 
formation/activation of NF-κB and the proto-oncogenes in cardiovascular 
tissues and VSM cells [14,25,26,64,65,70].
Sudden Cardiac Death is a Growing World-wide Problem
Sudden infant death syndrome (SIDS) has become a significant problem 
without an agreed-upon pathological mechanism(s) [71-76]. Explanations 
run the gamut from hypoxia, gene mutations, cardiac conduction 
abnormalities, inherited channelopathies, unknown infections, 
diaphragmatic dysfunctions, central hypoventillation, susceptibility to 
ventricular arrhythmias, etc.. Pediatric sudden cardiac arrest likewise 
seems, for the most part, to be a growing problem around the world with 
little in the way of an acceptable pathogenic mechaism(s) [71-76]. SCD 
accounts for approximately 20% of nearly all deaths in Western countries 
with multiple possible, but little agreed-upon explanations. SCD in the 
young (<35 yrs of age) has a structural/genetic basis in only about 20% 
of all cases in the Western World. In most of these SCD cases, there is no 
structural/pathological evidence for any heart abnormalities on autopsies 
[71-76].
Studies of Isolated Adult Mammalian and Human 
Coronary Arteries as well as Neonatal Piglet Coronary 
Arteries demonstrate Intense Vasospasm on Reduction in 
Extracellular Mg
Approximately 35 years ago, our laboratories reported that mammalian 
coronary arteries from neonates as well as adults (including those 
obtained from humans) demonstrate intense vasospasm as extracellular 
Mg2+ ([Mg2+]0) concentrations are lowered progressively in in-vitro 
studies; the lower the reduction in [Mg2+]0, and the smaller the coronary 
arterial vessel, the more intense the coronary arterial vasospasm [2-
4,14,25-31,55-62]. No vasodilator, including Ca2+ channel blockers can 
effectively alleviate these intense coronary vasospasms. These contractile 
actions of low Mg2+ are potentiated in the presence of neurohumoral and 
circulating vasoconstrictor agents, such as angiotensin II, vasopressin, 
serotonin, norepinephrine, and a variety of pressor peptides. Coronary 
arterial vessels, particularly small ones (<100 µm in diameter) obtained 
from neonatal piglets are exquisitely sensitive to low [Mg2+]0 levels. On the 
basis of our studies on the neonatal piglet coronaries, we suggested almost 
20 years ago, that low [Mg]0 could play an important role in SIDS and 
SCD [77]. Collectively, such findings lead us to conclude that low dietary 
Mg levels in pregnant women, infants and children must be taken into 
consideration as a major underlying mechanism for unexplained SCD in 
infants, children and young adults.
Low Serum Ionized Magnesium Levels found in Infants 
and Children in the USA
 In view of the above evidence and hypothesis, it is of considerable 
interest to point out, here, that several studies, including those done in our 
laboratories, have been published which indicate that infants and children 
in the USA demonstrate a much higher percentage of abnormally lowered 
serum total and ionized Mg levels when compared to adults 35-60 years 
of age [14,45,48,49,78-81 ]. Moreover, our studies on infants, children 
and pregnant women have shown a high percentage of abnormally low 
serum ionized Mg levels as well [14,52-54,82-84]. Taken together, we 
believe such clinical studies, collectively, provide substantial evidence for 
our hypothesis that unexplained SCD in infants and children possibly is 
due, in large measure, to abnormally low serum as well as low VSM and 
cardiac myocyte Mg2+ levels. With respect to the latter, we have shown, 
working with perfused rat hearts, that even short-term MgD results in 
reductions in a variety of hemodynamic functions, i.e., cardiac output, 
coronary flows, stroke volume, developed pressures, and cellular high-
energy phosphate levels with concomitant Ca2+ overload [85]. In 1996, 
we demonstrated on hearts excised from rats given low Mg diets that 
Mg depletion impairs carbohydrate metabolism and lipid metabolism 
and results in cardiac calcium overload [86]. We showed more than 40 
years ago that Mg2+ blocks the entry and intracellular release of Ca2+ from 
both VSM and cardiac myocytes [55,57,59,86-88]. This together with the 
adverse effects on both cardiac hemodynamics and energy production 
(and utilization) would perforce seriously compromise young hearts and 
result in SCD.
Is Genesis and Release of Platelet-Activating Factor (PAF) 
the Major Downstream Signal for induction of Coronary 
Arterial Vasospasm seen in Low Mg Environments?
Approximately 18 years ago, we reported that reduction of extracellular 
Mg2+ levels resulted in generation of variety PAF-like lipids, as seen with 
proton nuclear magnetic resonance spectroscopy [87]. At that time, 
we suggested that one or more of these PAF-like molecules may be an 
initiator of low Mg2+-induced arterial vasopasm and atherogenesis 
[87]. Over the intervening two decades, we have found that peripheral, 
cerebral and coronary arterial vessels, including neonatal coronaries, 
undergo contraction in the presence of low concentrations (<10-6 M) of 
PAF by acting on specific VSM membrane PAF receptors [88]. Moreover, 
the intense arterial vasospasms observed as [Mg2+]0 is lowered can be 
dramatically attenuated in the presence of specific PAF- membrane 
receptor blocking drugs [88]. In addition, our new findings indicate that 
as [Mg2+]0 is lowered, a rapid (within seconds) generation and release 
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of PAF is observed in the cultured VSM cells, including those obtained 
from neonatal piglets [88]. PAF is now thought to be an important, 
maybe critical, molecule in etiology of inflammatory conditions and 
atherosclerosis [89-91]. We thus believe that our new findings suggest 
major roles for MgD and PAF formation (and PAF-like lipids) in the 
cardiovascular manifestations of MgD, inflammation, atherogenesis, and 
SCD in children.
Approximately 40 years ago, Russell Ross and colleagues [92] advanced 
the hypothesis that atherosclerosis is an inflammatory disease brought 
about by injury to the endothelial surfaces of blood vessels in the macro- 
and microcirculations. The hypothesis stated that different forms of injury 
(including hypoxia and ischemia) will result in numerous dysfunctions 
in the homeostatic properties of the blood vessels and the underlying 
vascular smooth muscle cells, e.g., adhesiveness of leukocytes and/or 
platelets, formation/release of cytokines/chemokines and growth factors; 
all of these entities needed for atherogenesis are produced in MgD states. 
We believe low [Mg2+]0 environments act as triggers to induce local 
hypoxic and ischemic events within the macro- and microcirculations 
to initiate inflammatory-atherosclerotic sites via initial generation and 
release of Ca2+ and PAF. These events could be expected to take place in 
developing fetuses in-utero and after birth. Since most diets consumed 
in the Western World are deficient in Mg by as much as 65% below 
the RDAs for adults, infants and the young, such circumstances would 
perforce result in inflammatory conditions, vasospams, atherogenesis, 
and SCD.
Conclusions
This article reviews the evidence for a brand-new, novel hypothesis 
which combines evidence suggesting a combined role for hypomagnesemia 
and PAF which may provide insights into unexplained SCD in infants, 
children, and young adults. This report not only documents what takes 
place in the cardiovascular system when the body and its tissues are 
subjected to lower than normal dietary Mg intake, but provides new 
evidence for a series of heretofore unknown actions of PAF that are most 
likely involved and/or trigger arterial vasospasm in the presence of low 
[Mg2+]0 and probably is a major trigger for unexplained SCD.
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